564 related articles for article (PubMed ID: 14602903)
1. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
[TBL] [Abstract][Full Text] [Related]
2. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
3. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
Leng M; Locker D; Giraud-Panis MJ; Schwartz A; Intini FP; Natile G; Pisano C; Boccarelli A; Giordano D; Coluccia M
Mol Pharmacol; 2000 Dec; 58(6):1525-35. PubMed ID: 11093793
[TBL] [Abstract][Full Text] [Related]
4. DNA modifications by antitumor trans-[PtCl2(E-iminoether)2].
Zaludová R; Zákovská A; Kaspárkova J; Balcarová Z; Vrána O; Coluccia M; Natile G; Brabec V
Mol Pharmacol; 1997 Sep; 52(3):354-61. PubMed ID: 9281596
[TBL] [Abstract][Full Text] [Related]
5. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
Kasparkova J; Novakova O; Marini V; Najajreh Y; Gibson D; Perez JM; Brabec V
J Biol Chem; 2003 Nov; 278(48):47516-25. PubMed ID: 12970368
[TBL] [Abstract][Full Text] [Related]
6. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
7. The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA.
Zaludová R; Natile G; Brabec V
Anticancer Drug Des; 1997 Jun; 12(4):295-309. PubMed ID: 9199661
[TBL] [Abstract][Full Text] [Related]
8. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
[TBL] [Abstract][Full Text] [Related]
9. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G
Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659
[TBL] [Abstract][Full Text] [Related]
10. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V
Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
[TBL] [Abstract][Full Text] [Related]
11. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
Qu Y; Scarsdale NJ; Tran MC; Farrell NP
J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
[TBL] [Abstract][Full Text] [Related]
12. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
[TBL] [Abstract][Full Text] [Related]
13. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
[TBL] [Abstract][Full Text] [Related]
14. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
Zákovská A; Nováková O; Balcarová Z; Bierbach U; Farrell N; Brabec V
Eur J Biochem; 1998 Jun; 254(3):547-57. PubMed ID: 9688265
[TBL] [Abstract][Full Text] [Related]
15. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
Prokop R; Kasparkova J; Novakova O; Marini V; Pizarro AM; Navarro-Ranninger C; Brabec V
Biochem Pharmacol; 2004 Mar; 67(6):1097-109. PubMed ID: 15006546
[TBL] [Abstract][Full Text] [Related]
16. Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent.
Delalande O; Malina J; Brabec V; Kozelka J
Biophys J; 2005 Jun; 88(6):4159-69. PubMed ID: 15805172
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
Boccarelli A; Coluccia M; Intini FP; Natile G; Locker D; Leng M
Anticancer Drug Des; 1999 Jun; 14(3):253-64. PubMed ID: 10500500
[TBL] [Abstract][Full Text] [Related]
18. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
19. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
Kasparkova J; Farrell N; Brabec V
J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955
[TBL] [Abstract][Full Text] [Related]
20. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
